Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “B7H3”

19 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 19 of 19 results

Early research (Phase 1)Looking for participantsNCT07193628
What this trial is testing

B7H3/IL13Ra2 Bispecific Armored Chimeric Antigen Receptor T-Cell Therapy Study for Recurrent/Refractory Glioblastoma

Who this might be right for
Refractory GlioblastomaRecurrent Glioblastoma
Second Affiliated Hospital, School of Medicine, Zhejiang University 14
Early research (Phase 1)Looking for participantsNCT06305299
What this trial is testing

Autologous CAR-T Cells Targeting B7H3 in Ovarian Cancer iC9-CAR.B7-H3 T Cells

Who this might be right for
Ovary NeoplasmOvarian CancerEpithelial Ovarian Cancer+1 more
UNC Lineberger Comprehensive Cancer Center 27
Early research (Phase 1)Looking for participantsNCT06621563
What this trial is testing

Phase Ib Trial of HS-20117 in Combination With Other Drugs in Advanced Solid Tumors

Who this might be right for
Solid TumorsNon-Small Cell Lung CancerColorectal Cancer
Hansoh BioMedical R&D Company 780
Early research (Phase 1)Looking for participantsNCT07115446
What this trial is testing

Phase Ib Study of HS-20093+HRS-5041 in Patients With Advanced Prostate Cancer

Who this might be right for
Advanced Prostate Cancer
Hansoh BioMedical R&D Company 63
Large-scale testing (Phase 3)Looking for participantsNCT06954246
What this trial is testing

MHB088C Injection Versus Treatment of Physician's Choice in Subjects With Relapsed Small Cell Lung Cancer

Who this might be right for
Small Cell Lung Cancer Extensive Stage
Qilu Pharmaceutical Co., Ltd. 450
Very early researchLooking for participantsNCT06454955
What this trial is testing

Study on B7-H3 Targeted Affibody Radioligand Probes for PET Imaging of Solid Tumors

Who this might be right for
B7H3CD276 AffibodyPET/CT Imaing
Peking University Cancer Hospital & Institute 50
Very early researchLooking for participantsNCT05341492
What this trial is testing

EGFR/B7H3 CAR-T on Lung Cancer and Triple Negative Breast Cancer

Who this might be right for
EGFR/ B7H3-positive Advanced Lung CancerEGFR/ B7H3-positive Advanced Triple-negative Breast Cancer
Second Affiliated Hospital of Guangzhou Medical University 30
Not applicableStudy completedNCT06592092
What this trial is testing

Clinical Study of QH104 Cell Injection for the Treatment of Meningeal Metastases of B7H3+ Solid Tumors

Who this might be right for
Solid TumorMeningeal Metastasis
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 3
Testing effectiveness (Phase 2)Looking for participantsNCT06902389
What this trial is testing

A Clinical Study of Multi-target Hi-TCR-T Cells in the Treatment of Advanced Hepatocellular Carcinoma

Who this might be right for
Advanced Hepatocellular Carcinoma (HCC)
Eastern Hepatobiliary Surgery Hospital 30
Not applicableLooking for participantsNCT07152236
What this trial is testing

Clinical Study on the Safety and Efficacy of B7H3 CAR T Cells in Patients With B7H3 Positive Solid Tumors

Who this might be right for
Solid Tumors
Guangzhou Bio-gene Technology Co., Ltd 20
Early research (Phase 1)Looking for participantsNCT06612645
What this trial is testing

Safety and Efficacy of CMD03 CAR T Cell in Children With Relapse or Refractory Solid Tumors

Who this might be right for
Pediatric CancersSolid Tumor Pediatric
Chulalongkorn University 9
Testing effectiveness (Phase 2)Looking for participantsNCT05211557
What this trial is testing

Study of Fully Human B7H3 CAR-T in Treating Recurrent Malignant Ovarian Cancer

Who this might be right for
Ovarian Cancer
The Affiliated Hospital of Xuzhou Medical University 15
Very early researchNot Yet RecruitingNCT06825455
What this trial is testing

Allogeneic B7H3 CAR-γδT Cell Therapy for Advanced Solid Tumors

Who this might be right for
Advanced Solid TumorsOvarian CancersPeritoneal (metastatic) Cancer
Peking University 18
Early research (Phase 1)Active Not RecruitingNCT06422520
What this trial is testing

A First-in-Human Study of BGB-C354 Alone and in Combination With Tislelizumab in Participants With Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumor
BeOne Medicines 120
Early research (Phase 1)Active Not RecruitingNCT04483778
What this trial is testing

B7H3 CAR T Cell Immunotherapy for Recurrent/Refractory Solid Tumors in Children and Young Adults

Who this might be right for
Pediatric Solid TumorGerm Cell TumorRetinoblastoma+14 more
Seattle Children's Hospital 68
Early research (Phase 1)Looking for participantsNCT06221553
What this trial is testing

Safety and Efficacy of Loco-regional B7H3 IL-7Ra CAR T Cell in DIPG

Who this might be right for
DIPG Brain TumorDiffuse Intrinsic Pontine Glioma
Chulalongkorn University 9
Testing effectiveness (Phase 2)Looking for participantsNCT05323201
What this trial is testing

Study Of B7H3 CAR-T Cells in Treating Advanced Liver Cancer

Who this might be right for
Hepatocellular Carcinoma
The Affiliated Hospital of Xuzhou Medical University 15
Testing effectiveness (Phase 2)Looking for participantsNCT06778603
What this trial is testing

B7-H3 NIR Imaging for Osteosarcoma Surgery

Who this might be right for
OsteosarcomaResection MarginsB7-H3 Probe+1 more
Peking University People's Hospital 32
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07408063
What this trial is testing

A Comprehensive Multiomic Biomarker Evaluation Across Two Single-arm Cohorts to Elucidate Mechanisms of Response and Resistance in Recurrent/Metastatic (R/M) Head and Neck Squamous Cell Carcinoma (HNSCC)

Who this might be right for
Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma
University Health Network, Toronto 30